Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 December 2022 | Story Gerda-Marié van Rooyen | Photo Supplied
Olebogeng TIhong
Olebogeng TIhong loves stages and cameras. She is currently studying law.

An ex-CyberSta presenter has recently made her soap debut in The River.

Olebogeng Tlhong, a fourth-year LLB student at the UFS, recently portrayed the part of a celebrity, something she says works perfectly with her personality. However, acting is only one of her many gifts and interests.

She also owns an enterprise. “I established my online store in 2020 during the COVID-19 pandemic and registered my company in October 2021.” This company, a segment of Greys World, consists of an events company, bikini line, cosmetics and accessory stores and a clothing aspect.

Passionate about the entertainment space

This born Johannesburger describes herself as a “vibrant, hard-working, resilient and multifaceted woman who loves life and all that it has to offer”. Confidence is something she has in ample supply. “I have always been a confident individual. I have participated in public-speaking competitions from a young age. I am passionate about the entertainment space.” She loves people too. "I draw inspiration from different people for different reasons and aspects of my life. This includes from the women in my family to service workers’ stories, celebrity figures and the teachings of Christ.” 

Visualisation is something this entertainer strongly believes in. “The kind of life that I envision for myself, inspires me. I want to own my time and live on my terms. Having a vision board and holding myself accountable has played a large role in ensuring that I execute everything that I said I would. I believe in being proactive and solution based.” 

Crossing boundaries and achieving dreams

Olebogeng dreams of leaving a legacy echoing her courage to cross boundaries and achieve her dreams. “I want people to draw inspiration from me and know that they can achieve anything – regardless of obstacles or one’s past. One can build an empire from nothing,” says this wanna-be world traveller.

While it is uncertain where Olebogeng’s river will take her, one thing is certain, she’ll always seize the day. “I want to remain teachable to grow. The aim is to never get comfortable and to keep striving for more.”

 


 

Olebogeng appeared on The River, episode 240, that aired beginning/mid-October.

 


 

This guest appearing actress has always been confident. “I used to participate in public speaking competitions from a young age and I love the entertainment space.”

 


 

“Enjoy university, meet new people and grab every opportunity that aligns with your purpose, have fun and most importantly, ensure that your academics are always in order,” Olebogeng advises the first-year students of 2023.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept